Sagimet Biosciences (SGMT) stock dips as Chinese partner Ascletis (ASCLF) reports Phase 3 trial data for the U.S. firm's acne ...
Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label ...
Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label study - The ...
“The influencers do not lie,” says one reviewer. “This stuff is magic!” ...
A new study published in the Annals of Medicine and Surgery showed that the severity of acne was not significantly correlated ...
WEIFANG, SHANDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- 1. Rising Global Demand for PDT LED Light Therapy As ...
Kick off 2026 With the Top 25 Hottest FSA- and HSA-eligible Products from FSA Store (R) and HSA Store (R) Health-E Commerce (R) parent brand to FSA Store (R) and HSA Store (R) , gets your New Year's ...
As of Tuesday, January 13, Sensus Healthcare, Inc.’s SRTS share price has surged by 10.65%, which has investors questioning ...
From contrast therapy to rhythmic health, experts are placing renewed focus on recovery, rest, and repair. Read on for some ...
New Zealand's Kanuka oil is emerging as a potent skincare contender, challenging Manuka oil's reign.
From contrast therapy to rhythmic health, experts are predicting a renewed focus on recovery, rest, and repair The wellness ...
“Consumer trust is the ultimate currency. Brands with a compelling value proposition and combination of transparency, science-backed claims and authentic engagement will outperform over the long run,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results